Salman Fazal
Hematology & Oncology · Harrisburg, PA
CMS Profile ID: 298467 · NPI: 1588755904
Total Disclosed General Payments
$579,790.31
General-payment records
418
CMS Program Year
2025
Most of this (about 71%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $409,563.50 |
| Travel and Lodging | $88,127.08 |
| Honoraria | $42,411.00 |
| Consulting Fee | $31,609.26 |
| Food and Beverage | $8,079.47 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Incyte Corporation | $108,782.69 |
| TAIHO ONCOLOGY, INC. | $67,220.12 |
| GlaxoSmithKline, LLC. | $55,489.17 |
| Syndax Pharmaceuticals, Inc. | $51,845.84 |
| Blueprint Medicines Corporation | $48,600.53 |
| Janssen Biotech, Inc. | $46,769.25 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1588755904 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1588755904.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.